,,ii #aahth ,,congress #ast ,session ,s4 #aaca ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,march #cj1 #bjbc,mr4 ,braun 7for himself and ,mrs4 ,hyde-,smith7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to amend title ,,xi of the ,social ,security ,act and title ,,xxvii of the ,public ,health ,service ,act to establish requirements with respect to prescription drug benefits4 #a4 ,short title ,this ,act may be cited as the ,drug ,price ,transparency ,act of #bjbc4 #b4 ,requirements for prescription drug benefits 7a7 ,removal of safe harbor protection for rebates involving prescription drugs and establishment of new safe harbor protections involving prescription drugs 7#a7 ,removal of safe harbor protection for rebates involving prescription drugs ,section #aabh;,b7b7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;b7b77 is amended-- 7,a7 in paragraph 7#c77;,a71 by striking a discount and inserting subject to paragraph 7#e71 a discount2 and 7,b7 by adding at the end the following3 7#e7 ,removal of safe harbor protection for rebates involving prescription drugs ,the safe harbor described in paragraph 7#c77;,a7 shall not apply to a reduction in price or other remuneration from a manufacturer of prescription drugs to a sponsor of a prescription drug plan under part ,d of title ,,xviii1 an ,,ma organization offering an ,,ma-,,pd plan under part ,c of such title1 or a pharmacy benefit manager under contract with such a sponsor or such an organization and1 except as provided in subparagraphs 7,m7 and 7,n7 of paragraph 7#c71 paragraphs 7#a7 and 7#b7 shall apply to any such reduction in price or other remuneration4 4 7#b7 ,establishment of new safe harbor protections involving prescription drugs ,section #aabh;,b7b77#c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acbj;a-#g;b7b77#c77 is amended-- 7,a7 in subparagraph 7,k71 by striking and at the end2 7,b7 in subparagraph 7,l71 by striking the period at the end and inserting a semicolon2 and 7,c7 by adding at the end the following3 7,m7 a reduction in price offered by a manufacturer of prescription drugs to a sponsor of a prescription drug plan under part ,d of title ,,xviii1 an ,,ma organization offering an ,,ma-,,pd plan under part ,c of such title1 or a pharmacy benefit manager under contract with such a sponsor or such an organization1 that is reflected at the point of sale to the individual and meets such other conditions as the ,secretary may establish2 and 7,n7 flat fee service fees a manufacturer of prescription drugs pays to a pharmacy benefit manager for services rendered to the manufacturer that relate to arrangements by the pharmacy benefit manager to provide pharmacy benefit management services to a health plan1 if certain conditions established by the ,secretary are met1 including requirements that the fees are transparent to the health plan4 4 7#c7 ,effective date ,the amendments made by this subsection shall take effect on ,january #a1 #bjbd4 7b7 ,requirements for private insurance plans 7#a7 ,in general ,part ,d of title ,,xxvii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aaa et seq47 is amended by adding at the end the following3 #bgii;,a-#aa4 ,requirements with respect to prescription drug benefits 7a7 ,in general ,a group health plan or a health insurance issuer offering group or individual health insurance coverage shall not1 and shall ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan or health insurance coverage does not1 receive from a drug manufacturer a reduction in price or other remuneration with respect to any prescription drug received by an enrollee in the plan or coverage and covered by the plan or coverage1 unless-- 7#a7 any such reduction in price is reflected at the point of sale to the enrollee and meets such other conditions as the ,secretary may establish2 and 7#b7 any such other remuneration is a flat fee-based service fee that a manufacturer of prescription drugs pays to an entity that provides pharmacy benefits management services for services rendered to the manufacturer that relate to arrangements by the pharmacy benefit manager to provide pharmacy benefit management services to a health plan or health insurance issuer1 if certain conditions established by the ,secretary are met1 including requirements that the fees are transparent to the health plan or health insurance issuer4 7b7 ,entity that provides pharmacy benefits management services ,for purposes of this section1 the term entity that provides pharmacy benefits management services means-- 7#a7 any person1 business1 or other entity that1 pursuant to a written agreement with a group health plan or a health insurance issuer offering group or individual health insurance coverage1 directly or through an intermediary-- 7,a7 acts as a price negotiator on behalf of the plan or coverage2 or 7,b7 manages the prescription drug benefits provided by the plan or coverage1 which may include the processing and payment of claims for prescription drugs1 the performance of drug utilization review1 the processing of drug prior authorization requests1 the adjudication of appeals or grievances related to the prescription drug benefit1 contracting with network pharmacies1 controlling the cost of covered prescription drugs1 or the provision of related services2 or 7#b7 any entity that is owned1 affiliated1 or related under a common ownership structure with a person1 business1 or entity described in paragraph 7#a74 4 7#b7 ,,erisa 7,a7 ,in general ,subpart ,b of part #g of subtitle ,b of title ,i of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #aahe et seq47 is amended by adding at the end the following3 #gbf4 ,requirements with respect to prescription drug benefits 7a7 ,in general ,a group health plan or a health insurance issuer offering group health insurance coverage shall not1 and shall ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan or health insurance coverage does not1 receive from a drug manufacturer a reduction in price or other remuneration with respect to any prescription drug received by an enrollee in the plan or coverage and covered by the plan or coverage1 unless-- 7#a7 any such reduction in price is reflected at the point of sale to the enrollee and meets such other conditions as the ,secretary may establish2 and 7#b7 any such other remuneration is a flat fee-based service fee that a manufacturer of prescription drugs pays to an entity that provides pharmacy benefits management services for services rendered to the manufacturer that relate to arrangements by the pharmacy benefit manager to provide pharmacy benefit management services to a health plan or health insurance issuer1 if certain conditions established by the ,secretary are met1 including requirements that the fees are transparent to the health plan or health insurance issuer4 7b7 ,entity that provides pharmacy benefits management services ,for purposes of this section1 the term entity that provides pharmacy benefits management services means-- 7#a7 any person1 business1 or other entity that1 pursuant to a written agreement with a group health plan or a health insurance issuer offering group health insurance coverage1 directly or through an intermediary-- 7,a7 acts as a price negotiator on behalf of the plan or coverage2 or 7,b7 manages the prescription drug benefits provided by the plan or coverage1 which may include the processing and payment of claims for prescription drugs1 the performance of drug utilization review1 the processing of drug prior authorization requests1 the adjudication of appeals or grievances related to the prescription drug benefit1 contracting with network pharmacies1 controlling the cost of covered prescription drugs1 or the provision of related services2 or 7#b7 any entity that is owned1 affiliated1 or related under a common ownership structure with a person1 business1 or entity described in paragraph 7#a74 4 7,b7 ,clerical amendment ,the table of contents of the ,employee ,retirement ,income ,security ,act of #aigd is amended by inserting after the item relating to section #gbe the following3 ,sec4 #gbe4 ,requirements with respect to prescription drug benefits4 4 7#c7 ,,irc 7,a7 ,in general ,subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following3 #ihbf4 ,requirements with respect to prescription drug benefits 7a7 ,in general ,a group health plan shall not1 and shall ensure that any entity that provides pharmacy benefits management services under a contract with any such health plan does not1 receive from a drug manufacturer a reduction in price or other remuneration with respect to any prescription drug received by an enrollee in the plan and covered by the plan1 unless-- 7#a7 any such reduction in price is reflected at the point of sale to the enrollee and meets such other conditions as the ,secretary may establish2 and 7#b7 any such other remuneration is a flat fee-based service fee that a manufacturer of prescription drugs pays to an entity that provides pharmacy benefits management services for services rendered to the manufacturer that relate to arrangements by the pharmacy benefit manager to provide pharmacy benefit management services to a health plan1 if certain conditions established by the ,secretary are met1 including requirements that the fees are transparent to the health plan4 7b7 ,entity that provides pharmacy benefits management services ,for purposes of this section1 the term entity that provides pharmacy benefits management services means-- 7#a7 any person1 business1 or other entity that1 pursuant to a written agreement with a group health plan1 directly or through an intermediary-- 7,a7 acts as a price negotiator on behalf of the plan2 or 7,b7 manages the prescription drug benefits provided by the plan1 which may include the processing and payment of claims for prescription drugs1 the performance of drug utilization review1 the processing of drug prior authorization requests1 the adjudication of appeals or grievances related to the prescription drug benefit1 contracting with network pharmacies1 controlling the cost of covered prescription drugs1 or the provision of related services2 or 7#b7 any entity that is owned1 affiliated1 or related under a common ownership structure with a person1 business1 or entity described in paragraph 7#a74 4 7,b7 ,clerical amendment ,the table of sections for subchapter ,b of chapter #ajj of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following3 ,sec4 #ihaf4 ,requirements with respect to prescription drug benefits4 4 7#d7 ,effective date ,the amendments made by paragraphs 7#a71 7#b71 and 7#c7 shall take effect on ,january #a1 4